INVERT GRAPHITE LIMITED
ASX:IVGPharmaceuticals, Biotechnology & Life SciencesRunway 2–4 quarters; 2 cash raises in 24 months; share count grew 5% in 24 months
INVERT GRAPHITE LIMITED's ordinary share count rose 5.4% between May 2025 and June 2026, to 361M shares. The company raised capital twice in the 24-month window for total disclosed proceeds of A$6.0M, most recently a A$2.5M placement in June 2026 described as "Placement (in connection with acquisition) / scrip consideration". Options and rights could convert into 15M new shares, equal to 4.2% of the current share count, with 0% in the money at the current share price and the nearest expiry in June 2027. At the June 2026 quarter the company reported A$1.3M in cash, representing 3.3 quarters of cover. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in August 2026.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | Total on issue after | Source |
|---|---|---|---|---|
| 26 June 2026 | 3G · unquoted | IVG : ORDINARY FULLY PAID | 361.0M | Appendix 3G |
| 5 June 2026 | 2A · quoted issue | IVG : ORDINARY FULLY PAID | 361.0M | Appendix 2A |
| 2 Jan 2026 | 3H · cancellation | IVG : ORDINARY FULLY PAID | 342.5M | Appendix 3H |
| 13 Oct 2025 | 3H · cancellation | IVG : ORDINARY FULLY PAID | 342.5M | Appendix 3H |
| 19 Sept 2025 | 3G · unquoted | IVG : ORDINARY FULLY PAID | 342.5M | Appendix 3G |
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Pending proposed issues
Options & convertible securities
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.